In Vitro Skin Models as Non-Animal Methods for Dermal Drug Development and Safety Assessment.

Area of Science:

• Dermatology and Toxicology
• Biotechnology and Biomedical Engineering

Background:

• In vitro skin models have evolved significantly, driven by the need for ethical, efficient, and reliable alternatives to animal testing.
• Increased regulatory demands and ethical considerations fuel the development of sophisticated human skin models.

Purpose of the Study:

• To review the diverse types of in vitro skin models, their applications, and recent advancements.
• To explore the strengths, limitations, and future perspectives of in vitro skin models in research and industry.

Main Methods:

• Review of existing literature on in vitro skin model development and applications.
• Analysis of techniques like bioprinting and organ-on-a-chip in model manufacturing.
• Examination of models for general and disease-specific applications.

Main Results:

• In vitro skin models utilize diverse cell types to mimic physiological skin environments for precise product interaction studies.
• Applications span toxicity testing, dermatological product evaluation, skin aging research, and drug development.
• Bioprinting and organ-on-a-chip technologies are revolutionizing model creation, though challenges in vascularization and architecture remain.

Conclusions:

• In vitro skin models are crucial for advancing dermatological research and the cosmetic industry, reducing reliance on animal testing.
• Continued innovation in model development promises more accurate and predictive tools for skin research.
• Addressing challenges in vascularization and skin architecture will further enhance the utility of these advanced models.